GORE® SYNECOR Biomaterial is not authorized for use in Canada.

2.5 x

stronger than BD® BARD® Soft Mesh*,3,4

14%

Stronger than BD® VENTRALIGHT® ST Mesh*,4,5

ZERO

fractures reported†,‡

Permanent mesh solution for ventral hernia repair with the strength of a heavyweight, built like a lightweight and a low rate of infection for high BMI or co-morbid patients.1-7 All these benefits are realized at a lower cost than BD® VENTRALIGHT® ST Mesh.†,§ 

STRENGTH

Permanent devices

Strength, permanent devices

Ball burst strengthII (N)

GORE® SYNECOR Biomaterial 

surgery-red
< 1% recurrence rate in ventral hernia working group (VHWG) 1 and 2 patients1,2

body-surgery-red
< 2.2% surgical site infection (SSI) rate over 12-24 months1,2 

Robotic Surgery-red
Easy to use in minimally invasive procedures (laparoscopic, robotic) and open surgeries6,7 
See the real-world evidence: Evaluation of long-term performance of an intraperitoneal biomaterial in the treatment of ventral hernias—Surgical Endoscopy December, 2023
Gore ventral hernia solutions balance strength with a low rate of complications for your high-risk patients which is backed by†,¶:
 
  • 15 years of extensive clinical literature in soft tissue reinforcement†
  • Over 200 publications††
  • More than 5,000 cases in literature††

 

ENFORM intraperitoneal and preperitoneal images both folded over to show texture. Close up of material texture and pattern shown in circle

See it in action

      Is an absorbable device what your co-morbid patients need?

      GORE® ENFORM Biomaterial is 25% stronger than BD® PHASIX® Mesh with zero mesh removals or erosions reported.†, **, ††,§§,8
      Learn more

      * Includes only the permanent component of these products.
      † Data on file, W. L. Gore & Associates, Inc; Flagstaff, AZ.
      ‡ No confirmed reports of fracture.
      § Cost savings are based on 90 days post-operative outcomes.
      II Bench-top evaluations are intended to demonstrate relative physical characteristics and may not correlate to clinical results.
      GORE® BIO-A® Tissue Reinforcement, GORE® ENFORM Biomaterial and GORE® SYNECOR Biomaterial.
      ** No confirmed or published complete mesh removals due to infection or erosions reported.
      †† A literature search was performed by an Information Specialist in 2024 using the DIMENSIONS® Database, EMBASE® Database, and MEDLINE® on DIALOG® Database. Key words/phrases are on file. 
      ‡‡ Largest range of sizes currently available in a permanent heavyweight soft tissue reinforcement device in the United States as of July 2024.
      §§ Out-of-the-box strength.

      1. Linn JG, Mallico EJ, Doerhoff CR, Grantham DW, Washington RG Jr. Evaluation of long-term performance of an intraperitoneal biomaterial in the treatment of ventral hernias. Surgical Endoscopy 2023;37:3455-3462.
      2. Rios-Diaz A, Hitchner M, Christopher AN, Broach R, Cunning JR, Fischer JP. Early clinical and patient-reported outcomes of a new hybrid mesh for incisional hernia repair. Journal of Surgical Research 2021;265:49-59.
      3. Olson TB. Competitive Hernia Device Strength Evaluation. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2016. [Work plan]. WP108484.
      4. W. L. Gore & Associates, Inc. Plexus Knit PQ Validation Report. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2022. [Validation Report]. MD145325. Rev 5.
      5. Olson TB. Ventralight ST Strength after 14 and 28 day Degradation of Absorbable Components. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2016. [Work plan]. WP108781.
      6. W. L. Gore & Associates, Inc. GORE SYNECOR Intraperitoneal Biomaterial Design Control (DC) Matrix. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2023. [Design Control Matrix – DC Matrix]. MD184278. Rev 3.
      7. W. L. Gore & Associates, Inc. GORE SYNECOR Preperitoneal Biomaterial Design Control (DC) Matrix. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2023. [Design Control Matrix – DC Matrix]. MD187124. Rev 3.
      8. Deeken CR, Matthews BD. Characterization of the mechanical strength, resorption properties, and histologic characteristics of a fully absorbable material (Poly-4-hydroxybutyrate-PHASIX Mesh) in a porcine model of hernia repair. ISRN Surgery 2013;2013:238067.

      BD, BARD, PHASIX and VENTRALIGHT are trademarks of C.R. Bard, Inc.
      DIMENSIONS is a trademark of Digital Science & Research Solutions Inc.
      EMBASE is a trademark of Elsevier Limited.
      DIALOG is a trademark of Proquest LLC.
      MEDLINE is a trademark of The National Library of Medicine. 

      IFU Consult instructions

      Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available.  RXOnly 

      INDICATIONS FOR USE: The GORE® SYNECOR Intraperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall or thoracic wall soft tissue deficiencies that may require the addition of a nonabsorbable reinforcing or bridging material.

      CONTRAINDICATIONS: The GORE® SYNECOR Intraperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects.

      INDICATIONS FOR USE: The GORE® SYNECOR Preperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall soft tissue deficiencies that may require the addition of a non-absorbable reinforcing or bridging material.  

      CONTRAINDICATIONS: The GORE® SYNECOR Preperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects. 

      24GP1093-EN01